is hims semaglutide fda approved Novo Nordisk calls out dangers of compounded GLP-1s in new ad Hims & Hers Stock Pops

A retrospective cohort analysis showed the mean 12-month all-cause medical costs to be $US9624 for patients not incurring a hospitalization, $US42,011 for those with an inpatient admission but no 30-day readmission, and $US76,806 for patients with both an inpatient admission and 30-day readmission [9]

Thinking about food is pretty normal

This isn't a factor of obesity either

Tirzepatides are a class of Glucagon-like Peptide-1 receptor agonists and is one of the GLP-1/GIP medications that are used for Diabetes and Weight Loss

By reducing obesity-related inflammation and oxidative stress, its plausible that retatrutide could create a healthier environment for spermatogenesis